Practical Approach for Angina and Non-Obstructive Coronary Arteries: A State-of-the-Art Review.
ANOCA
Abnormal vasodilatory capacity
Coronary microvascular disease
Vasospasm
Journal
Korean circulation journal
ISSN: 1738-5520
Titre abrégé: Korean Circ J
Pays: Korea (South)
ID NLM: 101247141
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
12
05
2023
accepted:
19
05
2023
medline:
1
8
2023
pubmed:
1
8
2023
entrez:
1
8
2023
Statut:
ppublish
Résumé
Anginal symptoms are frequently encountered in patients without the presence of significant obstructive coronary artery disease (CAD). It is increasingly recognized that vasomotor disorders, such as an abnormal vasodilatory capacity of the coronary microcirculation or coronary vasospasm, are the dominant pathophysiological substrate in these patients. Although the evidence with respect to angina in patients with non-obstructive coronary arteries is accumulating, the diagnosis and treatment of these patients remains challenging. In this review, we aimed to provide a comprehensive overview regarding the pathophysiological origins of angina with non-obstructive coronary arteries disorders and its diagnostic and therapeutic considerations. Hereby, we provide a practical approach for the management of patents with angina and non-obstructive CAD.
Identifiants
pubmed: 37525496
pii: 53.e52
doi: 10.4070/kcj.2023.0109
pmc: PMC10435829
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
519-534Informations de copyright
Copyright © 2023. The Korean Society of Cardiology.
Déclaration de conflit d'intérêts
Tim P. van de Hoef has received speaker fees and institutional research grants from Abbott and Philips. Jan J. Piek has received support as consultant for Philips/Volcano, and has received institutional research grants from Philips. Peter Damman received research grants, speaker and consultancy fees from Phillips, and research grants and speaker fees from Abbot. Marcel A.M. Beijk has received an institutional research grant from Actelion Pharmaceutical B.V. Coen K.M. Boerhout reports no conflict of interest relating to this work.
Références
Am J Prev Med. 2013 Aug;45(2):207-16
pubmed: 23867029
JACC Cardiovasc Interv. 2022 May 23;15(10):1060-1070
pubmed: 35589236
Circ Res. 1964 Mar;14:250-9
pubmed: 14133952
Medicine (Baltimore). 2020 Sep 11;99(37):e22167
pubmed: 32925783
J Cardiovasc Pharmacol. 2000 May;35(5):822-8
pubmed: 10813387
Eur Heart J. 2012 Mar;33(6):734-44
pubmed: 21911339
Korean Circ J. 2022 Nov;52(11):814-825
pubmed: 36217588
J Am Coll Cardiol. 2020 May 26;75(20):2538-2549
pubmed: 32439003
Circulation. 2019 Nov 26;140(22):1805-1816
pubmed: 31707835
Circ Cardiovasc Interv. 2013 Aug;6(4):329-35
pubmed: 23899871
Eur Heart J. 2017 Sep 1;38(33):2565-2568
pubmed: 26245334
J Cardiol. 2017 Jan;69(1):57-65
pubmed: 27856130
EuroIntervention. 2022 Feb 18;17(15):1271-1280
pubmed: 34278990
Eur Heart J. 2014 May;35(17):1101-11
pubmed: 24366916
Circulation. 1987 Mar;75(3):577-82
pubmed: 3815770
Int J Cardiol. 2015 Feb 15;181:376-81
pubmed: 25555283
JACC Cardiovasc Imaging. 2022 Aug;15(8):1473-1484
pubmed: 35466050
Circ J. 2010 Sep;74(9):1943-50
pubmed: 20668353
Cardiologia. 1999 Dec;44(12):1065-9
pubmed: 10687257
J Am Coll Cardiol. 2010 Jun 22;55(25):2825-32
pubmed: 20579539
Circulation. 1991 Nov;84(5):1984-92
pubmed: 1934373
Atherosclerosis. 2011 May;216(1):7-16
pubmed: 21411098
Am J Crit Care. 2004 Jul;13(4):350-4
pubmed: 15293589
JACC Cardiovasc Interv. 2022 Jan 10;15(1):65-75
pubmed: 34991826
Circ Res. 1990 Jun;66(6):1561-75
pubmed: 2160870
EuroIntervention. 2022 Oct 21;18(9):719-728
pubmed: 35694826
J Mol Cell Cardiol. 2012 Apr;52(4):794-801
pubmed: 22004900
J Cardiol. 2008 Feb;51(1):2-17
pubmed: 18522770
Circ Cardiovasc Interv. 2022 Aug;15(8):e012017
pubmed: 35904014
EuroIntervention. 2021 Jan 20;16(13):1049-1069
pubmed: 32624456
EuroIntervention. 2021 Oct 01;17(8):e672-e679
pubmed: 33528358
Eur Cardiol. 2020 Apr 06;15:e12
pubmed: 32373185
Korean Circ J. 2021 Feb;51(2):126-139
pubmed: 33525067
Circulation. 2011 Oct 18;124(16):1774-82
pubmed: 22007100
N Engl J Med. 2010 Mar 11;362(10):886-95
pubmed: 20220183
Neth Heart J. 2020 Aug;28(Suppl 1):66-72
pubmed: 32780334
Nat Rev Cardiol. 2015 Jan;12(1):48-62
pubmed: 25311229
Circulation. 1997 Jan 21;95(2):522-8
pubmed: 9008472
Int J Cardiol. 2023 May 15;379:1-8
pubmed: 36863419
Neth Heart J. 2021 Nov;29(11):551-556
pubmed: 34676522
Circulation. 2000 Mar 21;101(11):1319-23
pubmed: 10725293
Circ J. 2014;78(11):2779-801
pubmed: 25273915
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
JACC Cardiovasc Interv. 2014 Jun;7(6):581-91
pubmed: 24835328
Circulation. 2000 Mar 7;101(9):948-54
pubmed: 10704159
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2841-2855
pubmed: 30266608